Research peptides studied for anxiety reduction, stress response modulation, and neuroprotection.
Anxiety and stress response modulation is an emerging area of peptide research. Several compounds have demonstrated anxiolytic effects through GABAergic modulation, HPA axis regulation, and neuroprotective mechanisms — often with fewer side effects than pharmaceutical anxiolytics.
Research Disclaimer: All content on this page is for educational and research purposes only. These compounds are not FDA-approved for human use. Always consult a qualified healthcare professional before considering any peptide protocol.
Selank is a synthetic analog of the endogenous peptide tuftsin with well-documented anxiolytic effects. It modulates GABA-A receptor activity and reduces cortisol response to stress. It has been studied in Russian clinical trials for generalized anxiety disorder.
Semax is an ACTH analog that modulates the HPA axis and increases BDNF. It has shown anxiolytic and nootropic effects in clinical research, reducing anxiety while improving cognitive function.
BPC-157 has shown anxiolytic effects in animal models, likely through dopaminergic and GABAergic modulation. It may reduce anxiety as a secondary effect of its broader neuroprotective and gut-brain axis activity.
Dihexa is a potent HGF potentiator that promotes synaptogenesis. While primarily studied for cognitive enhancement, it may reduce anxiety through improved neural connectivity and stress resilience.
Selank has the most direct evidence for anxiety reduction, with clinical trial data from Russian research institutions. It modulates GABA-A receptors similarly to benzodiazepines but without dependence or sedation.
Selank has a favorable safety profile in the available research. It does not produce the dependence, tolerance, or withdrawal associated with benzodiazepines. However, human clinical data is limited primarily to Russian studies.
Preclinical evidence suggests BPC-157 has anxiolytic properties, likely through dopaminergic modulation and gut-brain axis effects. Many researchers report reduced anxiety as a secondary benefit of BPC-157 protocols.
Purgo Labs provides pharmaceutical-grade research peptides with third-party COAs. Use code HEALTH for 15% off your first order.
Visit Purgo LabsMedical Disclaimer: All content on this site is for educational and research purposes only. Research peptides are not FDA-approved for human use. Always consult a qualified healthcare professional before considering any peptide or supplement protocol. Nothing on this site constitutes medical advice, diagnosis, or treatment.